MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.vph.2022.106994

Медицинская библиотека · Vascular pharmacology · 2022

The non-vitamin K antagonist oral anticoagulants and heparin-induced prolongation of the activated coagulation time.

Negro Francesco, Caravelli Paolo, Morganti Riccardo, Casini Monica, Ruocco Lucia, Tripodi Armando, De Caterina Raffaele

СтатьяПеревод в очереди

Аннотация

BACKGROUND AND AIMS: Unfractionated-heparin (UFH) is the first-choice parenteral anticoagulant during invasive percutaneous procedures and its effect is monitored by the activated coagulation time (ACT). The effects of the non-vitamin K antagonist oral anticoagulants (NOACs) on the ACT and on ACT prolongation by UFH were not clearly established. We assessed the ACT prolongation induced by different UFH concentrations in blood samples of patients taking the four types of currently marketed NOACs and in patients not taking anticoagulants.

METHODS AND

RESULTS

We measured the ACT in patients on dabigatran 110 mg (n = 8), rivaroxaban (n = 10), apixaban (n = 9) and edoxaban (n = 10) at supposed peak plasma concentrations, before and after in vitro addition of 3 UFH concentrations, corresponding to doses of 2000, 5000 and 10,000 IU. Seven non-anticoagulated patients served as controls. Patients in the 5 groups did not differ significantly for age, body weight and glomerular filtration rate. Baseline ACTs (s, mean ± SD) were 192 ± 27, 124 ± 14, 132 ± 14, 151 ± 30 and 134 ± 7 in dabigatran 110, rivaroxaban, apixaban, edoxaban and controls, respectively (P < 0.05 for dabigatran vs the other NOACs). We found a linear prolongation of the ACT with the in vitro UFH addition (P < 0.001), but prolongation was similar between the NOACs and controls.

CONCLUSIONS

Dabigatran induces a moderate, significant ACT prolongation. None of the NOACs affects the UFH-induced ACT prolongation in the commonly used UFH range. The dose of UFH currently recommended to achieve the target ACT should thus be used irrespective of whether patients are taking NOACs or not.

Для цитирования: Negro Francesco, Caravelli Paolo, Morganti Riccardo, Casini Monica, Ruocco Lucia, Tripodi Armando, De Caterina Raffaele. The non-vitamin K antagonist oral anticoagulants and heparin-induced prolongation of the activated coagulation time.. Vascular pharmacology. 2022. DOI: 10.1016/j.vph.2022.106994.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.